{"id":17235,"date":"2021-10-18T05:42:37","date_gmt":"2021-10-18T03:42:37","guid":{"rendered":"http:\/\/mabdesign.fr\/talem-therapeutics-announces-multi-target-antibody-discovery-research-collaboration-with-pierre-fabre\/"},"modified":"2021-10-18T05:42:37","modified_gmt":"2021-10-18T03:42:37","slug":"talem-therapeutics-announces-multi-target-antibody-discovery-research-collaboration-with-pierre-fabre","status":"publish","type":"post","link":"https:\/\/mabdesign.fr\/en\/talem-therapeutics-announces-multi-target-antibody-discovery-research-collaboration-with-pierre-fabre\/","title":{"rendered":"Talem Therapeutics Announces Multi-Target Antibody Discovery Research Collaboration with Pierre Fabre"},"content":{"rendered":"

Talem Therapeutics Announces Multi-Target Antibody Discovery Research Collaboration with Pierre Fabre<\/h1>\n

October 07, 2021 <\/em>\u2013 IMMUNOPRECISE ANTIBODIES LTD. (the \u201cCompany\u201d or \u201cIPA\u201d) (NASDAQ: IPA) (TSX VENTURE: IPA) and the Pierre Fabre pharmaceutical group announced today that IPA\u2019s subsidiary, Talem Therapeutics LLC (\u201cTalem\u201d), and Pierre Fabre have entered a multi-year, multi-target research collaboration with the goal to discover and develop therapeutics antibodies for up to nine targets. This strategic collaboration is expected to help expand Talem\u2019s portfolio of novel antibodies across oncology. It adds to the variety of diverse relationships that the IPA group of companies holds across the pharmaceutical and biotechnology sector. To know more<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Talem Therapeutics LLC (\u201cTalem\u201d), and Pierre Fabre have entered a multi-year, multi-target research collaboration with the goal to discover and develop therapeutics antibodies for up to nine targets.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[36,32],"tags":[],"class_list":["post-17235","post","type-post","status-publish","format-standard","hentry","category-news","category-our-members"],"yoast_head":"\nTalem Therapeutics Announces Multi-Target Antibody Discovery Research Collaboration with Pierre Fabre - MabDesign<\/title>\n<meta name=\"description\" content=\"Talem Therapeutics LLC (\u201cTalem\u201d), and Pierre Fabre have entered a multi-year, multi-target research collaboration with the goal to discover and develop therapeutics antibodies for up to nine targets.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mabdesign.fr\/en\/talem-therapeutics-announces-multi-target-antibody-discovery-research-collaboration-with-pierre-fabre\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Talem Therapeutics Announces Multi-Target Antibody Discovery Research Collaboration with Pierre Fabre - MabDesign\" \/>\n<meta property=\"og:description\" content=\"Talem Therapeutics LLC (\u201cTalem\u201d), and Pierre Fabre have entered a multi-year, multi-target research collaboration with the goal to discover and develop therapeutics antibodies for up to nine targets.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mabdesign.fr\/en\/talem-therapeutics-announces-multi-target-antibody-discovery-research-collaboration-with-pierre-fabre\/\" \/>\n<meta property=\"og:site_name\" content=\"MabDesign\" \/>\n<meta property=\"article:published_time\" content=\"2021-10-18T03:42:37+00:00\" \/>\n<meta name=\"author\" content=\"alexis.mathias@kairios.fr\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:site\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"alexis.mathias@kairios.fr\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/mabdesign.fr\/en\/talem-therapeutics-announces-multi-target-antibody-discovery-research-collaboration-with-pierre-fabre\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/talem-therapeutics-announces-multi-target-antibody-discovery-research-collaboration-with-pierre-fabre\/\"},\"author\":{\"name\":\"alexis.mathias@kairios.fr\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135\"},\"headline\":\"Talem Therapeutics Announces Multi-Target Antibody Discovery Research Collaboration with Pierre Fabre\",\"datePublished\":\"2021-10-18T03:42:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/talem-therapeutics-announces-multi-target-antibody-discovery-research-collaboration-with-pierre-fabre\/\"},\"wordCount\":115,\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"articleSection\":[\"News\",\"Our members\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/mabdesign.fr\/en\/talem-therapeutics-announces-multi-target-antibody-discovery-research-collaboration-with-pierre-fabre\/\",\"url\":\"https:\/\/mabdesign.fr\/en\/talem-therapeutics-announces-multi-target-antibody-discovery-research-collaboration-with-pierre-fabre\/\",\"name\":\"Talem Therapeutics Announces Multi-Target Antibody Discovery Research Collaboration with Pierre Fabre - MabDesign\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\"},\"datePublished\":\"2021-10-18T03:42:37+00:00\",\"description\":\"Talem Therapeutics LLC (\u201cTalem\u201d), and Pierre Fabre have entered a multi-year, multi-target research collaboration with the goal to discover and develop therapeutics antibodies for up to nine targets.\",\"breadcrumb\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/talem-therapeutics-announces-multi-target-antibody-discovery-research-collaboration-with-pierre-fabre\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/mabdesign.fr\/en\/talem-therapeutics-announces-multi-target-antibody-discovery-research-collaboration-with-pierre-fabre\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/mabdesign.fr\/en\/talem-therapeutics-announces-multi-target-antibody-discovery-research-collaboration-with-pierre-fabre\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/mabdesign.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Talem Therapeutics Announces Multi-Target Antibody Discovery Research Collaboration with Pierre Fabre\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"name\":\"Mabdesign\",\"description\":\"The Biotherapy Expert\",\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/mabdesign.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\",\"name\":\"Mabdesign\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"width\":786,\"height\":233,\"caption\":\"Mabdesign\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/MabDesign_fr\",\"https:\/\/www.linkedin.com\/company\/mabdesign\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135\",\"name\":\"alexis.mathias@kairios.fr\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g\",\"caption\":\"alexis.mathias@kairios.fr\"},\"sameAs\":[\"http:\/\/mabdesign.fr\"],\"url\":\"https:\/\/mabdesign.fr\/en\/author\/amathiasigtcreative-fr\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Talem Therapeutics Announces Multi-Target Antibody Discovery Research Collaboration with Pierre Fabre - MabDesign","description":"Talem Therapeutics LLC (\u201cTalem\u201d), and Pierre Fabre have entered a multi-year, multi-target research collaboration with the goal to discover and develop therapeutics antibodies for up to nine targets.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mabdesign.fr\/en\/talem-therapeutics-announces-multi-target-antibody-discovery-research-collaboration-with-pierre-fabre\/","og_locale":"en_US","og_type":"article","og_title":"Talem Therapeutics Announces Multi-Target Antibody Discovery Research Collaboration with Pierre Fabre - MabDesign","og_description":"Talem Therapeutics LLC (\u201cTalem\u201d), and Pierre Fabre have entered a multi-year, multi-target research collaboration with the goal to discover and develop therapeutics antibodies for up to nine targets.","og_url":"https:\/\/mabdesign.fr\/en\/talem-therapeutics-announces-multi-target-antibody-discovery-research-collaboration-with-pierre-fabre\/","og_site_name":"MabDesign","article_published_time":"2021-10-18T03:42:37+00:00","author":"alexis.mathias@kairios.fr","twitter_card":"summary_large_image","twitter_creator":"@MabDesign_fr","twitter_site":"@MabDesign_fr","twitter_misc":{"Written by":"alexis.mathias@kairios.fr","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mabdesign.fr\/en\/talem-therapeutics-announces-multi-target-antibody-discovery-research-collaboration-with-pierre-fabre\/#article","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/talem-therapeutics-announces-multi-target-antibody-discovery-research-collaboration-with-pierre-fabre\/"},"author":{"name":"alexis.mathias@kairios.fr","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135"},"headline":"Talem Therapeutics Announces Multi-Target Antibody Discovery Research Collaboration with Pierre Fabre","datePublished":"2021-10-18T03:42:37+00:00","mainEntityOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/talem-therapeutics-announces-multi-target-antibody-discovery-research-collaboration-with-pierre-fabre\/"},"wordCount":115,"publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"articleSection":["News","Our members"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/mabdesign.fr\/en\/talem-therapeutics-announces-multi-target-antibody-discovery-research-collaboration-with-pierre-fabre\/","url":"https:\/\/mabdesign.fr\/en\/talem-therapeutics-announces-multi-target-antibody-discovery-research-collaboration-with-pierre-fabre\/","name":"Talem Therapeutics Announces Multi-Target Antibody Discovery Research Collaboration with Pierre Fabre - MabDesign","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/#website"},"datePublished":"2021-10-18T03:42:37+00:00","description":"Talem Therapeutics LLC (\u201cTalem\u201d), and Pierre Fabre have entered a multi-year, multi-target research collaboration with the goal to discover and develop therapeutics antibodies for up to nine targets.","breadcrumb":{"@id":"https:\/\/mabdesign.fr\/en\/talem-therapeutics-announces-multi-target-antibody-discovery-research-collaboration-with-pierre-fabre\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mabdesign.fr\/en\/talem-therapeutics-announces-multi-target-antibody-discovery-research-collaboration-with-pierre-fabre\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/mabdesign.fr\/en\/talem-therapeutics-announces-multi-target-antibody-discovery-research-collaboration-with-pierre-fabre\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/mabdesign.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Talem Therapeutics Announces Multi-Target Antibody Discovery Research Collaboration with Pierre Fabre"}]},{"@type":"WebSite","@id":"https:\/\/mabdesign.fr\/en\/#website","url":"https:\/\/mabdesign.fr\/en\/","name":"Mabdesign","description":"The Biotherapy Expert","publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mabdesign.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/mabdesign.fr\/en\/#organization","name":"Mabdesign","url":"https:\/\/mabdesign.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","width":786,"height":233,"caption":"Mabdesign"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/MabDesign_fr","https:\/\/www.linkedin.com\/company\/mabdesign\/"]},{"@type":"Person","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135","name":"alexis.mathias@kairios.fr","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g","caption":"alexis.mathias@kairios.fr"},"sameAs":["http:\/\/mabdesign.fr"],"url":"https:\/\/mabdesign.fr\/en\/author\/amathiasigtcreative-fr\/"}]}},"_links":{"self":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/17235","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/comments?post=17235"}],"version-history":[{"count":0,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/17235\/revisions"}],"wp:attachment":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media?parent=17235"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/categories?post=17235"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/tags?post=17235"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}